US Stock MarketDetailed Quotes
SGMO Sangamo Therapeutics
- 2.360
- +0.100+4.42%
Close Dec 2 16:00 ET
- 2.290
- -0.070-2.97%
Post 19:58 ET
492.41MMarket Cap-3323P/E (TTM)
2.370High2.150Low3.55MVolume2.270Open2.260Pre Close8.08MTurnover1.74%Turnover RatioLossP/E (Static)208.65MShares3.17952wk High12.55P/B481.53MFloat Cap0.30452wk Low--Dividend TTM204.04MShs Float51.375Historical High--Div YieldTTM9.74%Amplitude0.291Historical Low2.274Avg Price1Lot Size
Sangamo Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 425.77%49.41M | -94.79%356K | -99.70%481K | 58.34%176.23M | -92.50%2.04M | -64.48%9.4M | -76.73%6.84M | 459.52%157.96M | 0.54%111.3M | -2.70%27.23M |
| Operating revenue | 425.77%49.41M | -94.79%356K | -99.70%481K | 58.34%176.23M | -92.50%2.04M | -64.48%9.4M | -76.73%6.84M | 459.52%157.96M | 0.54%111.3M | -2.70%27.23M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -45.38%38.78M | -54.13%36.27M | -41.42%47.66M | -5.55%295.22M | -22.77%63.81M | -12.72%71.01M | 5.26%79.06M | 10.70%81.35M | 6.31%312.58M | 21.71%82.62M |
| Selling and administrative expenses | -20.61%11.05M | -24.78%12.05M | -35.12%11.77M | -2.42%61.17M | -20.34%13.1M | -14.29%13.92M | 6.10%16.01M | 21.65%18.14M | -0.85%62.68M | 2.23%16.44M |
| -General and administrative expense | -20.61%11.05M | -24.78%12.05M | -35.12%11.77M | -2.42%61.17M | -20.34%13.1M | -14.29%13.92M | 6.10%16.01M | 21.65%18.14M | -0.85%62.68M | 2.23%16.44M |
| Research and development costs | -51.42%27.73M | -61.58%24.22M | -43.22%35.89M | -6.34%234.06M | -23.38%50.71M | -12.33%57.09M | 5.04%63.05M | 7.91%63.22M | 8.27%249.9M | 27.76%66.18M |
| Operating profit | 117.26%10.63M | 50.28%-35.91M | -161.58%-47.18M | 40.88%-118.99M | -11.50%-61.76M | -12.23%-61.61M | -57.92%-72.23M | 269.25%76.61M | -9.79%-201.28M | -38.83%-55.39M |
| Net non-operating interest income expense | -96.33%129K | -63.24%1.03M | -23.02%2.54M | 17.71%11.1M | -59.43%1.49M | 98.70%3.52M | 6.02%2.8M | 145.38%3.29M | 76.43%9.43M | 57.45%3.68M |
| Non-operating interest income | -96.33%129K | ---- | ---- | 17.71%11.1M | -59.43%1.49M | 98.70%3.52M | ---- | ---- | 76.43%9.43M | --3.68M |
| Total other finance cost | ---- | 63.24%-1.03M | 23.02%-2.54M | ---- | ---- | ---- | -6.02%-2.8M | -145.38%-3.29M | ---- | ---- |
| Other net income (expense) | 97.72%-1.17M | 92.57%-4.35M | -155.01M | -296K | -44.8M | -51.35M | -58.57M | |||
| Special income (charges) | --0 | 97.72%-1.17M | 92.57%-4.35M | ---155.01M | ---296K | ---44.8M | ---51.35M | ---58.57M | --0 | --0 |
| -Less:Impairment of capital assets | --0 | -97.72%1.17M | -92.57%4.35M | --155.01M | --296K | --44.8M | --51.35M | --58.57M | --0 | --0 |
| Income before tax | 110.46%10.76M | 70.15%-36.05M | -329.71%-48.99M | -37.04%-262.9M | -17.12%-60.57M | -93.68%-102.89M | -180.27%-120.77M | 148.56%21.33M | -7.79%-191.85M | -37.67%-51.71M |
| Income tax | -93.07%88K | 101.18%74K | -49.48%98K | -1,282.28%-5.07M | -205.02%-272K | 4,133.33%1.27M | -7,739.02%-6.26M | 234.48%194K | 40.20%429K | 486.57%259K |
| Net income | 110.25%10.67M | 68.45%-36.13M | -332.29%-49.09M | -34.09%-257.83M | -16.01%-60.3M | -95.96%-104.16M | -165.23%-114.51M | 148.05%21.13M | -7.84%-192.28M | -38.61%-51.97M |
| Net income continuous Operations | 110.25%10.67M | 68.45%-36.13M | -332.29%-49.09M | -34.09%-257.83M | -16.01%-60.3M | -95.96%-104.16M | -165.23%-114.51M | 148.05%21.13M | -7.84%-192.28M | -38.61%-51.97M |
| Minority interest income | 0 | 0 | ||||||||
| Net income attributable to the parent company | 110.25%10.67M | 68.45%-36.13M | -332.29%-49.09M | -34.09%-257.83M | -16.01%-60.3M | -95.96%-104.16M | -165.23%-114.51M | 148.05%21.13M | -7.85%-192.28M | -38.61%-51.97M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 1.29M | 0 | ||||||||
| Net income attributable to common stockholders | 109.01%9.39M | 68.45%-36.13M | -332.29%-49.09M | -34.09%-257.83M | -16.01%-60.3M | -95.96%-104.16M | -165.23%-114.51M | 148.05%21.13M | -7.85%-192.28M | -38.61%-51.97M |
| Basic earnings per share | 108.47%0.05 | 72.73%-0.18 | -307.69%-0.27 | -18.40%-1.48 | -6.25%-0.34 | -73.53%-0.59 | -127.59%-0.66 | 143.33%0.13 | -1.63%-1.25 | -23.08%-0.32 |
| Diluted earnings per share | 106.78%0.04 | 72.73%-0.18 | -325.00%-0.27 | -18.40%-1.48 | -6.25%-0.34 | -73.53%-0.59 | -127.59%-0.66 | 140.00%0.12 | -1.63%-1.25 | -23.08%-0.32 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
